Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +13332.9% | +4372.4% | 2 / 3 | -13.7% | +4.62 pp | +15.49 pp | +0.9% | 0.07 | 16.98 | 56,7 | −13,7% | 8,8 | +13.332,9% | 16.98 | 9.64 | +76,2% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 8.810 (close price on 2026-10-13)EPS (TTM): 518,8
Financial charts
1.Revenue & growth
VND bn56,7Q2/26
1.Revenue & growth
VND bn56,7Q2/26
2.Profit & growth
VND bn-1,38Q2/26
3.Profit mix (Penman)
VND bn-3,13Q2/26
4.Margins & cost structure
%28.4%Q2/26
5.Returns & cash cycle
% · days0.2%Q2/26
6.Earnings quality & cash
VND bn56,5Q2/26
7.Asset structure
VND bn916Q2/26
8.Funding & debt health
VND bn · times916Q2/26
9.Revenue backlog
VND bn9,46Q2/26
10.Valuation
times · %-44,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-99Q2/26
Adjusted EPS growth, latest quarter
-2199%
Average adjusted EPS growth, 3 quarters
-805%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26